Humana stock slides again as Medicare Advantage rate proposal keeps pressure on insurers
Humana shares fell 6.1% to $195.31 by midday Wednesday, extending a sharp two-day selloff after U.S. Medicare officials proposed a 0.09% average payment increase for 2027. Investors are watching for final rates in April and Humana’s February 11 earnings. The proposal raised concerns about potential benefit cuts and tighter margins for Medicare Advantage insurers.